PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
317 hedge funds and large institutions have $10.1B invested in PRA Health Sciences, Inc. in 2021 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 104 increasing their positions, 125 reducing their positions, and 58 closing their positions.
233% more funds holding in top 10
Funds holding in top 10: 6 → 20 (+14)
6% more capital invested
Capital invested by funds: $9.55B → $10.1B (+$546M)
9% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 58
2% less funds holding
Funds holding: 323 → 317 (-6)
2.21% less ownership
Funds ownership: 96.53% → 94.32% (-2.2%)
17% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 125
58% less call options, than puts
Call options by funds: $1.47M | Put options by funds: $3.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$580M |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
+$530M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$256M |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$246M |
| 5 |
E
Ergoteles
New York
|
+$160M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$700M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$581M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$403M |
| 4 |
BlackRock
New York
|
-$379M |
| 5 |
Janus Henderson Group
London,
|
-$368M |
PRAH Hedge Fund Activity: Q2 2021 in Review
317 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2021, worth a combined $10.1B — up 5.7% from $9.55B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of PRAH and 53 opened new positions — a net loss of 5 holders — while 125 trimmed existing stakes and 104 added.
The largest buyer was Millennium Management, adding an estimated $580M. The largest seller was Vanguard Group, cutting an estimated $700M.
- 317 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2021, down from 323 in Q1 2021.
- Funds reported $10.1B of PRA Health Sciences, Inc. stock for Q2 2021, up 5.7% quarter-over-quarter.
- 53 funds opened new PRA Health Sciences, Inc. positions in Q2 2021 and 58 closed out, a net change of -5 holders.
- The largest PRA Health Sciences, Inc. buyer in Q2 2021 was Millennium Management, an estimated $580M added.
- The largest PRA Health Sciences, Inc. seller in Q2 2021 was Vanguard Group, an estimated $700M sold.
Based on aggregated 13F filings for Q2 2021.